Repligen
| Type | Public |
|---|---|
| Nasdaq: RGEN S&P 400 Component | |
| Industry | Biotechnology Laboratory equipment |
| Founded | 1981 |
| Founders | Alexander Rich Paul Schimmel |
| Headquarters | Waltham, Massachusetts , United States |
| Key people | Olivier Loeillot (president and CEO) |
| Products | Materials used in the manufacture of biological drugs |
| Revenue | |
Number of employees | c. 2,000 (2025) |
| Website | repligen |
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN.